GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » EV-to-EBITDA

Pharmaresearch Bio Co (XKRX:217950) EV-to-EBITDA : 11.58 (As of May. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pharmaresearch Bio Co's enterprise value is ₩97,210 Mil. Pharmaresearch Bio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩8,391 Mil. Therefore, Pharmaresearch Bio Co's EV-to-EBITDA for today is 11.58.

The historical rank and industry rank for Pharmaresearch Bio Co's EV-to-EBITDA or its related term are showing as below:

XKRX:217950' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.53   Med: 35.51   Max: 709.88
Current: 11.59

During the past 6 years, the highest EV-to-EBITDA of Pharmaresearch Bio Co was 709.88. The lowest was 7.53. And the median was 35.51.

XKRX:217950's EV-to-EBITDA is ranked worse than
54.44% of 450 companies
in the Biotechnology industry
Industry Median: 9.57 vs XKRX:217950: 11.59

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), Pharmaresearch Bio Co's stock price is ₩28400.00. Pharmaresearch Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩569.000. Therefore, Pharmaresearch Bio Co's PE Ratio for today is 49.91.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Pharmaresearch Bio Co EV-to-EBITDA Historical Data

The historical data trend for Pharmaresearch Bio Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co EV-to-EBITDA Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial 387.85 50.75 28.69 11.91 7.57

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA Get a 7-Day Free Trial 387.85 50.75 28.69 11.91 7.57

Competitive Comparison of Pharmaresearch Bio Co's EV-to-EBITDA

For the Biotechnology subindustry, Pharmaresearch Bio Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaresearch Bio Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's EV-to-EBITDA falls into.



Pharmaresearch Bio Co EV-to-EBITDA Calculation

Pharmaresearch Bio Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=97209.511/8391.091
=11.58

Pharmaresearch Bio Co's current Enterprise Value is ₩97,210 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pharmaresearch Bio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩8,391 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaresearch Bio Co  (XKRX:217950) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pharmaresearch Bio Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=28400.00/569.000
=49.91

Pharmaresearch Bio Co's share price for today is ₩28400.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pharmaresearch Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩569.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Pharmaresearch Bio Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaresearch Bio Co (XKRX:217950) Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines